The/DT
hematopoietic/JJ
transcription/NN
factor/NN
PU.1/NN
is/VBZ
downregulated/VBN
in/IN
human/JJ
multiple/JJ
myeloma/NN
cell/NN
lines/NNS
./.

PU.1/NN
is/VBZ
a/DT
hematopoietic/JJ
transcription/NN
factor/NN
belonging/VBG
to/TO
the/DT
Ets-family/NN
./.
=====
It/PRP
is/VBZ
identical/JJ
to/TO
the/DT
Spi-1/NN
oncogene/NN
,/,
which/WDT
is/VBZ
implicated/VBN
in/IN
spleen/NN
focus-forming/JJ
virus-induced/JJ
murine/JJ
erythroleukemias/NNS
./.
=====
PU.1/NN
seems/VBZ
to/TO
be/VB
required/VBN
for/IN
early/JJ
development/NN
of/IN
multiple/JJ
hematopoietic/JJ
lineages/NNS
,/,
but/CC
its/PRP$
expression/NN
in/IN
mature/JJ
cells/NNS
is/VBZ
preferentially/RB
observed/VBN
in/IN
cells/NNS
of/IN
the/DT
B-cell-and/NN
monocyte/macrophage-differentiation/NN
lineage/NN
./.
=====
It/PRP
binds/VBZ
the/DT
so-called/JJ
Pu/NN
box/NN
,/,
an/DT
important/JJ
tissue-specific/JJ
regulatory/JJ
DNA/NN
element/NN
present/JJ
in/IN
a/DT
number/NN
of/IN
genes/NNS
expressed/VBN
in/IN
these/DT
cell/NN
lineages/NNS
./.
=====
We/PRP
have/VBP
analyzed/VBN
the/DT
expression/NN
and/CC
activity/NN
of/IN
PU.1/NN
during/IN
human/JJ
B-cell/NN
development/NN
using/VBG
a/DT
panel/NN
of/IN
B-cell/NN
lines/NNS
representing/VBG
different/JJ
stages/NNS
of/IN
maturation/NN
,/,
from/IN
early/JJ
precursors/NNS
to/TO
differentiated/VBN
plasma/NN
cells/NNS
./.
=====
PU.1/NN
mRNA/NN
expression/NN
and/CC
PU.1/NN
DNA/NN
binding/NN
activity/NN
,/,
as/IN
measured/VBN
by/IN
Northern/NN
blot/NN
analysis/NN
and/CC
electrophoretic/JJ
mobility/NN
shift/NN
assay/NN
,/,
respectively/RB
,/,
were/VBD
evident/JJ
in/IN
cell/NN
lines/NNS
representing/VBG
pro-B/JJ
,/,
pre-B/JJ
,/,
and/CC
mature/JJ
B/NN
cells/NNS
./.
=====
We/PRP
could/MD
also/RB
show/VB
Pu/NN
box-dependent/JJ
transactivation/NN
of/IN
a/DT
reporter/NN
gene/NN
in/IN
transient/JJ
transfections/NNS
in/IN
these/DT
cell/NN
lines/NNS
./.
=====
In/IN
contrast/NN
,/,
in/IN
a/DT
number/NN
of/IN
multiple/JJ
myeloma/NN
cell/NN
lines/NNS
,/,
representing/VBG
differentiated/VBN
,/,
plasma/NN
cell-like/JJ
B/NN
cells/NNS
,/,
PU.1/NN
DNA/NN
binding/NN
activity/NN
,/,
mRNA/NN
expression/NN
,/,
and/CC
Pu/NN
box-dependent/JJ
transactivation/NN
were/VBD
absent/JJ
or/CC
detectable/JJ
at/IN
a/DT
very/RB
low/JJ
level/NN
./.
=====
In/IN
lymphoblastoid/JJ
cell/NN
lines/NNS
,/,
which/WDT
exemplify/VBP
an/DT
intermediate/JJ
stage/NN
of/IN
B-cell/NN
differentiation/NN
,/,
a/DT
reduced/VBN
expression/NN
and/CC
activity/NN
were/VBD
observed/VBN
./.
=====
The/DT
findings/NNS
in/IN
the/DT
human/JJ
multiple/JJ
myeloma/NN
cell/NN
lines/NNS
represent/VBP
the/DT
first/JJ
examples/NNS
of/IN
B/NN
cells/NNS
with/IN
downregulated/VBN
PU.1/NN
expression/NN
and/CC
apparently/RB
contradict/VBP
observations/NNS
in/IN
the/DT
murine/JJ
system/NN
in/IN
which/WDT
PU.1/NN
is/VBZ
expressed/VBN
and/CC
active/JJ
in/IN
plasmacytoma/NN
cell/NN
lines/NNS
./.
=====
At/IN
present/JJ
,/,
it/PRP
is/VBZ
unclear/JJ
whether/IN
the/DT
lack/NN
of/IN
PU.1/NN
expression/NN
and/CC
activity/NN
in/IN
human/JJ
multiple/JJ
myeloma/NN
cell/NN
lines/NNS
represents/VBZ
a/DT
malignancy-associated/JJ
defect/NN
in/IN
these/DT
cells/NNS
or/CC
exemplifies/VBZ
a/DT
normal/JJ
developmental/JJ
regulation/NN
in/IN
terminally/RB
differentiated/VBN
B/NN
cells/NNS
./.